1. Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients.
- Author
-
Han M, Ma K, Wang X, Yan W, Wang H, You J, Wang Q, Chen H, Guo W, Chen T, Ning Q, and Luo X
- Subjects
- Adult, Aged, CD4-Positive T-Lymphocytes pathology, CD8-Positive T-Lymphocytes pathology, COVID-19 blood, COVID-19 complications, COVID-19 mortality, China epidemiology, Cytokines analysis, Cytokines blood, Diabetes Mellitus, Type 2 blood, Diabetes Mellitus, Type 2 complications, Diabetes Mellitus, Type 2 mortality, Female, Humans, Hyperglycemia blood, Hyperglycemia complications, Hyperglycemia immunology, Hyperglycemia mortality, Immune System metabolism, Immune System pathology, Killer Cells, Natural pathology, Lymphocyte Count, Lymphopenia blood, Lymphopenia complications, Lymphopenia immunology, Lymphopenia mortality, Male, Middle Aged, Retrospective Studies, SARS-CoV-2 immunology, SARS-CoV-2 physiology, Th1 Cells pathology, Th2 Cells pathology, COVID-19 immunology, Diabetes Mellitus, Type 2 immunology
- Abstract
Clinical Trial Registration: www.ClinicalTrials.gov, identifier: NCT04365634., Context: Diabetes mellitus was associated with increased severity and mortality of disease in COVID-19 pneumonia. So far the effect of type 2 diabetes (T2DM) or hyperglycemia on the immune system among COVID-19 disease has remained unclear., Objective: We aim to explore the clinical and immunological features of type 2 diabetes mellitus (T2DM) among COVID-19 patients., Design and Methods: In this retrospective study, the clinical and immunological characteristics of 306 hospitalized confirmed COVID-19 patients (including 129 diabetic and 177 non-diabetic patients) were analyzed. The serum concentrations of laboratory parameters including cytokines and numbers of immune cells were measured and compared between diabetic and non-diabetic groups., Results: Compared with non-diabetic group, diabetic cases more frequently had lymphopenia and hyperglycemia, with higher levels of urea nitrogen, myoglobin, D-dimer and ferritin. Diabetic cases indicated the obviously elevated mortality and the higher levels of cytokines IL-2R, IL-6, IL-8, IL-10, and TNF-α, as well as the distinctly reduced Th1/Th2 cytokines ratios compared with non-diabetic cases. The longitudinal assays showed that compared to that at week 1, the levels of IL-6 and IL-8 were significantly elevated at week 2 after admission in non-survivors of diabetic cases, whereas there were greatly reductions from week 1 to week 2 in survivors of diabetic cases. Compared with survival diabetic patients, non-survival diabetic cases displayed distinct higher serum concentrations of IL-2R, IL-6, IL-8, IL-10, TNF-α, and lower Th1/Th2 cytokines ratios at week 2. Samples from a subset of participants were evaluated by flow cytometry for the immune cells. The counts of peripheral total T lymphocytes, CD4
+ T cells, CD8+ T cells and NK cells were markedly lower in diabetic cases than in non-diabetic cases. The non-survivors showed the markedly declined counts of CD8+ T cells and NK cells than survivors., Conclusion: The elevated cytokines, imbalance of Th1/Th2 cytokines ratios and reduced of peripheral numbers of CD8+ T cells and NK cells might contribute to the pathogenic mechanisms of high mortality of COVID-19 patients with T2DM., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Han, Ma, Wang, Yan, Wang, You, Wang, Chen, Guo, Chen, Ning and Luo.)- Published
- 2021
- Full Text
- View/download PDF